Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1

por Wheeler, T.M., Krym, M.C., Thornton, C.A.
Publicado 2007

Signal transducer and activator of transcription-3 licenses Toll-like receptor 4-dependent interleukin (IL)-6 and IL-8 production via IL-6 receptor-positive feedback in endometrial...

por Cronin, J G, Kanamarlapudi, V, Thornton, C A, Sheldon, I M
Publicado en Mucosal Immunol (2016)

Health education in schools.

por Thornton, C A, Brennan, R K, Browne, A D, Denham, P C
Publicado 1978

Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR.

por Tian, B, White, R J, Xia, T, Welle, S, Turner, D H, Mathews, M B, Thornton, C A
Publicado 2000

Bioenergetic analysis of human peripheral blood mononuclear cells

por Jones, N, Piasecka, J, Bryant, A H, Jones, R H, Skibinski, D O F, Francis, Nigel J, Thornton, C A
Publicado en Clin Exp Immunol (2015)

Human gestation‐associated tissues express functional cytosolic nucleic acid sensing pattern recognition receptors

por Bryant, A. H., Menzies, G. E., Scott, L. M., Spencer‐Harty, S., Davies, L. B., Smith, R. A., Jones, R. H., Thornton, C. A.
Publicado en Clin Exp Immunol (2017)

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1 [Image: see text]

por Logigian, E.L., Martens, W.B., Moxley, R.T., McDermott, M.P., Dilek, N., Wiegner, A.W., Pearson, A.T., Barbieri, C.A., Annis, C.L., Thornton, C.A., Moxley, R.T.
Publicado 2010

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

por Sorenson, E J., Windbank, A J., Mandrekar, J N., Bamlet, W R., Appel, S H., Armon, C, Barkhaus, P E., Bosch, P, Boylan, K, David, W S., Feldman, E, Glass, J, Gutmann, L, Katz, J, King, W, Luciano, C A., McCluskey, L F., Nash, S, Newman, D S., Pascuzzi, R M., Pioro, E, Sams, L J., Scelsa, S, Simpson, E P., Subramony, S H., Tiryaki, E, Thornton, C A.
Publicado 2008